Healthcare provider profile · identity verified

Kyle Ritchie Bahnsen, DNP

Nurse Practitioner · PITTSBURGH, PA · NPI 1548744279

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1430	59
Metoprolol Succinate	Metoprolol Succinate	806	32
Lisinopril	Lisinopril	734	28
Gabapentin	Gabapentin	705	30
Pantoprazole Sodium	Pantoprazole Sodium	675	29
Amlodipine Besylate	Amlodipine Besylate	636	35
Levothyroxine Sodium	Levothyroxine Sodium	613	27
Sertraline Hcl	Sertraline Hcl	575	26
Furosemide	Furosemide	516	35
Jardiance	Empagliflozin	506	27
Tamsulosin Hcl	Tamsulosin Hcl	466	20
Eliquis	Apixaban	452	21
Omeprazole	Omeprazole	410	23
Trazodone Hcl	Trazodone Hcl	396	21
Duloxetine Hcl	Duloxetine Hcl	376	18
Carvedilol	Carvedilol	335	13
Potassium Chloride	Potassium Chloride	335	30
Quetiapine Fumarate	Quetiapine Fumarate	321	14
Metformin Hcl	Metformin Hcl	269	14
Levetiracetam	Levetiracetam	251	13
Spironolactone	Spironolactone	248	13
Losartan Potassium	Losartan Potassium	239	15
Montelukast Sodium	Montelukast Sodium	231	suppressed
Metformin Hcl Er	Metformin Hcl	211	suppressed
Finasteride	Finasteride	208	suppressed
Valsartan	Valsartan	207	11
Mirtazapine	Mirtazapine	175	12
Fluoxetine Hcl	Fluoxetine Hcl	168	suppressed
Baclofen	Baclofen	163	suppressed
Aripiprazole	Aripiprazole	145	suppressed
Ropinirole Hcl	Ropinirole Hcl	145	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	124	suppressed
Buspirone Hcl	Buspirone Hcl	118	suppressed
Xarelto	Rivaroxaban	117	suppressed
Famotidine	Famotidine	116	16
Entresto	Sacubitril/Valsartan	114	suppressed
Januvia	Sitagliptin Phosphate	113	suppressed
Allopurinol	Allopurinol	112	suppressed
Prazosin Hcl	Prazosin Hcl	109	suppressed
Pravastatin Sodium	Pravastatin Sodium	108	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	102	suppressed
Risperidone	Risperidone	98	suppressed
Citalopram Hbr	Citalopram Hydrobromide	96	suppressed
Clonazepam	Clonazepam	92	suppressed
Clopidogrel	Clopidogrel Bisulfate	86	suppressed
Buprenorphine	Buprenorphine	85	13
Quetiapine Fumarate Er	Quetiapine Fumarate	85	suppressed
Perphenazine	Perphenazine	82	suppressed
Hydralazine Hcl	Hydralazine Hcl	79	suppressed
Trulicity	Dulaglutide	77	13
Bupropion Hcl Sr	Bupropion Hcl	76	suppressed
Fluticasone Propionate	Fluticasone Propionate	74	19
Escitalopram Oxalate	Escitalopram Oxalate	72	suppressed
Olanzapine	Olanzapine	71	suppressed
Alendronate Sodium	Alendronate Sodium	70	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	69	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	67	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	66	suppressed
Irbesartan	Irbesartan	66	suppressed
Simvastatin	Simvastatin	65	suppressed
Benztropine Mesylate	Benztropine Mesylate	64	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	suppressed
Carbamazepine Er	Carbamazepine	63	suppressed
Haloperidol	Haloperidol	63	suppressed
Tramadol Hcl	Tramadol Hcl	63	21
Metformin Er Osmotic	Metformin Hcl	62	suppressed
Bupropion Hcl	Bupropion Hcl	59	suppressed
Diclofenac Sodium	Diclofenac Sodium	57	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	56	18
Letrozole	Letrozole	55	suppressed
Ondansetron Hcl	Ondansetron Hcl	55	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	52	suppressed
Phenobarbital	Phenobarbital	51	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	51	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	48	suppressed
Verapamil Sr	Verapamil Hcl	48	suppressed
Bupropion Xl	Bupropion Hcl	47	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	47	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	47	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Lorazepam	Lorazepam	46	suppressed
Paroxetine Hcl	Paroxetine Hcl	46	suppressed
Midodrine Hcl	Midodrine Hcl	45	suppressed
Prednisone	Prednisone	43	15
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	11
Trintellix	Vortioxetine Hydrobromide	41	suppressed
Atenolol	Atenolol	40	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	suppressed
Methenamine Hippurate	Methenamine Hippurate	40	suppressed
Lithium Carbonate	Lithium Carbonate	39	suppressed
Fentanyl	Fentanyl	36	suppressed
Meloxicam	Meloxicam	35	suppressed
Cardizem La	Diltiazem Hcl	34	suppressed
Divalproex Sodium	Divalproex Sodium	34	suppressed
Ozempic	Semaglutide	33	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	33	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	32	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Dilantin	Phenytoin Sodium Extended	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Latanoprost	Latanoprost	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	19
Loperamide	Loperamide Hcl	29	11
Phenytek	Phenytoin Sodium Extended	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Lacosamide	Lacosamide	27	suppressed
Tramadol Hcl Er	Tramadol Hcl	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	11
Glipizide Er	Glipizide	24	suppressed
Lactulose	Lactulose	24	12
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Febuxostat	Febuxostat	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	17
Linzess	Linaclotide	22	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	21	suppressed
Mirabegron Er	Mirabegron	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	17
Auryxia	Ferric Citrate	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	11
Warfarin Sodium	Warfarin Sodium	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	11
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Invokana	Canagliflozin	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error